Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization

Ophthalmic Research

Volumn 35, Issue 5, 2003, Pages 239-246

  Yu, Wen Zhen ^a   Li, Xiao Xin ^a   She, Hai Cheng ^a   He, Pei Ying ^a   Dong, Jian Qiang ^a   Rui, Min ^b   Ma, Da Long ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Corneal neovascularization; DNA plasmid; Electroporation; Gene therapy; Kringle 5 of plasminogen; Rat

Indexed keywords

KRINGLE 5 OF PLASMINOGEN PROTEIN; PLASMID DNA; PLASMINOGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STRAIN COS1; COLORIMETRY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA INJURY; CORNEA NEOVASCULARIZATION; DRUG ACTIVITY; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CONJUNCTIVA; CORNEA; CORNEAL NEOVASCULARIZATION; COS CELLS; DISEASE MODELS, ANIMAL; ELECTROPORATION; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS; KRINGLES; MALE; PLASMIDS; PLASMINOGEN; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0042572526     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072143     Document Type: Article

References (31)

1. Edelman, JL, Castro MR, Wen Y: Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci 1999;40:1112-1123.
2. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci 1995;92:905-909.
3. Amano S, Roban R, Kuroki M, Tolentino M, Adamis AP: Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998;39:18-22.
4. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu HJ, Benedict W, Bouck NP: Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999;285:245-248.
5. Hill JC, Maske R: An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 1988;46:26-30.
6. Cao YH, Chen A, An S, Ji RW, Davidson D, Cao YM, Llinas M: Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 1997;36:22924-22928.
7. Lu H, Dhanabal M, Volk R, Waterman MJF, Ramchandran R, Knebelmann B, Segal M, Sukhatme VP: Kringle 5 cause cell cycle arrest and apoptosis of endothelial cells. Biochem Biophys Res Commun 1999;258:668-673.
8. Ji WR, Barrientos LG, Llinas M, Gray H, Villarreal X, DeFord ME, Castellino FJ, Kramer RA, Trail PA: Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun 1998;247:414-419.
9. Zhang D, Kaufman PL, Gao G, Saunders RA, Ma JX: Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia 2001;44:757-765.
10. Sakamoto T, Ueno H, Goto Y, Oshima Y, Yamanaka I, Ishibashi T, Inomata H: Retinal functional change caused by adenoviral vector-mediated transfection of lacZ gene. Hum Gene Ther 1998;9:789-799.
11. Lai CC, Wu WC, Chen SL, Xiao X, Tsai TC, Huan SJ, Chen TL, Tsai RF, Tsao YP: Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest Ophthalmol Vis Sci 2001;42:2401-2407.
12. Lai CM, Brankov M, Zaknich T, Lai YK, Shen WY, Constable IL, Kovesdi I, Rakoczy PE: Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovasularization. Hum Gene Ther 2001;12:1299-1310.
13. Masuda I, Matsuo T, Yasuda T, Matsuo N: Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 1996;37:1914-1920.
14. Stechschulte SU, Joussen AM, Von Recum HA, Poulaki V, Moromizato Y, Yuan J, D'Amato RJ, Kuo C, Adamis AP: Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci 2001;42:1975-1979.
15. Moore JE, McMullen TCB, Campbell IL, Roban R, Kaji Y, Afsbari NA, Usui T, Arcber DB, Adamis AP: The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Invest Ophthalmol Vis Sci 2002;43:2905-2915.
16. Blezinger P, Wang J, Gondo M, Quezada A, Mehrens D, French M, Singhal A, Sullivan S, Rolland A, Ralston R, Min W: Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 1999;17:343-348.
17. Song Y, Wang Z, Li Y, Laties A, Wen Y: Adenovirally delivered angiostatin, endostatin, or kringle 5 of plasminogen inhibits corneal angiogenesis in rats after alkali injury. Invest Ophthalmol Vis Sci 2001;42:S480.
18. Ormerod LD, Ablson MB, Kenyon KR: Standard models of corneal injury using alkali-immersed filter disc. Invest Ophthalmol Vis Sci 1989;30:2148-2153.
19. Blair-Parks K, Weston BC, Dean DA: High-level gene transfer to the cornea using electroporation. J Gene Med 2002;4:92-100.
20. Mahoney J, Waterbury LD: Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res 1985;4:531-535.
21. Totan Y, Aydin E, Cekic O, Daglioglu MC, Borazan M, Daglioglu K, Gultek A: Effect of caffeic acid phenethyl ester on corneal neovascularization in rats. Curr Eye Res 2001;23:291-297.
22. Liu ZG, Zhang ZH, Ma JX, Zhang M, Luo LH, Xiao QG, Lin JX, Zhang P, Chen JQ: An experimental study of anti-angiogenesis with recombinant human kringle 5. Chin J Ophthalmol 2002;38:415-418.
23. Griffioen AW, Molema G: Angiogenesis: Potential for pharmacologic intervention in treatment of cancer, cardiovascular disease, and chronic inflammation. Pharmacol Rev 2000;52:237-268.
24. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285.
25. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
26. Kolber DL, Knisely TL, Maione TE: Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J Natl Cancer Inst 1995;87:303-309.
27. Gorrin-Rivas MJ, Arii S, Furutani M, Mizumoto M, Mori A, Hanaki K, Maeda M, Furuyama H, Kondo Y, Imamura M: Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumour growth by halting angiogenesis. Clin Cancer Res 2000;6:1647-1654.
28. Chen QR, Kumar D, Stass SA, Mixson AJ: Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res 1999;59:3308-3312.
29. Horton HM, Anderson D, Hernandez P, Barnhart KM, Norman JA, Parker SE: A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha. Proc Natl Acad Sci USA 1999;96:1553-1558.
30. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG: Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 1993;4:733-740.
31. Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C: Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther 1998;9:575-585.